These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30504509)

  • 1. Cytomegaloviral or
    Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC
    J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
    Yu Q; Jia P; Su L; Zhao H; Que C
    BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage fluid analysis and mortality risk in systemic lupus erythematosus patients with pneumonia and respiratory failure.
    Lai CC; Sun YS; Lin FC; Yang CY; Tsai CY
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1048-1055. PubMed ID: 32675043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
    Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
    Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study.
    Chan SCW; Chung HY; Lau CS; Li PH
    Ann Clin Microbiol Antimicrob; 2021 Nov; 20(1):78. PubMed ID: 34763703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
    Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
    BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis.
    Vetter M; Battegay M; Trendelenburg M
    Infection; 2010 Aug; 38(4):331-4. PubMed ID: 20393781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.
    Zhang Y; Zheng Y
    Rheumatol Int; 2014 Dec; 34(12):1765-71. PubMed ID: 24948376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
    Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S
    Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus and Pneumocystis carinii pneumonia in children with acquired immunodeficiency syndrome.
    Glaser JH; Schuval S; Burstein O; Bye MR
    J Pediatr; 1992 Jun; 120(6):929-31. PubMed ID: 1317421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: Clinical manifestations and outcomes between pediatric and adult patients.
    Lee HY; Lu CY; Lee PI; Chen JM; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2019 Dec; 52(6):983-990. PubMed ID: 31164278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia.
    Fillatre P; Chevrier S; Revest M; Gacouin A; Jouneau S; Leroy H; Robert-Gangneux F; Minjolle S; Le Tulzo Y; Tattevin P
    Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):189-94. PubMed ID: 22930407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan.
    Weng CT; Liu MF; Weng MY; Lee NY; Wang MC; Lin WC; Ou CY; Lai WW; Hsu SC; Chao SC; Chung TJ; Lee CT; Shieh CC; Wang JY; Wang CR
    J Clin Rheumatol; 2013 Aug; 19(5):252-8. PubMed ID: 23872548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of Pneumocystis jirovecii pneumonia and prophylaxis prescribing patterns in a large electronic health record cohort of patients with systemic lupus erythematosus.
    Boone B; Lazaroff SM; Wheless L; Wolfe RM; Barnado A
    Semin Arthritis Rheum; 2022 Dec; 57():152106. PubMed ID: 36279805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease.
    Bozzette SA; Arcia J; Bartok AE; McGlynn LM; McCutchan JA; Richman DD; Spector SA
    J Infect Dis; 1992 Jan; 165(1):93-8. PubMed ID: 1309375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMV pneumonia in HIV-infected ventilated infants.
    Goussard P; Kling S; Gie RP; Nel ED; Heyns L; Rossouw GJ; Janson JT
    Pediatr Pulmonol; 2010 Jul; 45(7):650-5. PubMed ID: 20575098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection.
    Kim T; Moon SM; Sung H; Kim MN; Kim SH; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
    Scand J Infect Dis; 2012 Sep; 44(9):670-7. PubMed ID: 22264016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
    Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
    Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia.
    Beam E; Germer JJ; Lahr B; Yao JDC; Limper AH; Binnicker MJ; Razonable RR
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29112278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.
    Kilic A; Elliott S; Hester L; Palavecino E
    J Mycol Med; 2020 Jun; 30(2):100936. PubMed ID: 32044156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.